Soluble PD1 enhances anti-immunity in orthotopic bladder tumors by strengthening CD8 T cell response

被引：0
|
作者：
Seo, H-H [1 ]
Jeong, N-R [1 ]
Seo, H. K. [2 ]
Jung, Y. S. [3 ]
Lee, S-J [1 ]
机构：
[1] Natl Canc Ctr, Genitourinary Canc Branch, Res Inst, Gyeonggi Do 460719, South Korea
[2] Natl Canc Ctr, Ctr Prostate Canc, Res Inst, Gyeonggi Do 460719, South Korea
[3] Natl Canc Ctr, Ctr Thyroid Canc, Res Inst, Gyeonggi Do 460719, South Korea
来源：
HUMAN GENE THERAPY | 2013年 / 24卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A169 / A169
页数：1
相关论文
共 50 条
  • [31] Antigen dominance hierarchies shape CD8 T cell phenotypes and immunotherapy response in tumors
    Burger, Megan L.
    Cruz, Amanda M.
    Crossland, Grace E.
    Gaglia, Giorgio
    Ritch, Cecily C.
    Blatt, Sarah E.
    Bhutkar, Arjun
    Tavana, Sara Z.
    Santagata, Sandro
    Jacks, Tyler
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [32] Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer
    Wei Zhang
    Long Shi
    Zhilong Zhao
    Pingping Du
    Xueshuai Ye
    Dongbin Li
    Zhenhua Cai
    Jinsheng Han
    Jianhui Cai
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 911 - 920
  • [33] PD-1 regulates response to bystander activation of memory CD8 T cells
    Le, Catherine
    Dunai, Cordelia
    Khuat, Lam T.
    Murphy, William J.
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [34] Nuclear HMGB1 is critical for CD8 T cell IFN-γ production and anti-tumor immunity
    Xu, Zhiguang
    Ma, Weiying
    Wang, Ji
    Chen, Haofan
    Li, Hui
    Yin, Zhinan
    Hao, Jianlei
    Chen, Kebing
    CELL REPORTS, 2024, 43 (08):
  • [35] Therapeutic vaccination enhances 4-1BB-mediated anti-tumor CD8 T cell immunity against poorly immunogenic haematological cancers
    Doff, B.
    Soon, M.
    Kobayashi, T.
    McKee, S.
    Mattarollo, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 810 - 810
  • [36] An MHC class Ib-restricted CD8 T cell response confers antiviral immunity
    Swanson, Phillip A., II
    Pack, Christopher D.
    Hadley, Annette
    Wang, Chyung-Ru
    Stroynowski, Iwona
    Jensen, Peter E.
    Lukacher, Aron E.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (07): : 1647 - 1657
  • [37] CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models
    Lv, Zhuangwei
    Zhang, Ping
    Li, Dandan
    Qin, Mengting
    Nie, Longzhu
    Wang, Xiaoqian
    Ai, Li
    Feng, Zhaozu
    Odhiambo, Woodvine Otieno
    Ma, Yunfeng
    Ji, Yanhong
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [38] YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
    Lebid, Andriana
    Chung, Liam
    Pardoll, Drew M.
    Pan, Fan
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [39] CD8 T cell mediated viral clearance is inhibited by PD-1 ligand
    Ramakrishna, Chandran
    Stohlman, Stephen A.
    Malone, Karen
    Macklin, Wendy
    Bergmann, Cornelia C.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S130 - S130
  • [40] PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens
    Martina Damo
    Noah I. Hornick
    Aarthi Venkat
    Ivana William
    Kathryn Clulo
    Srividhya Venkatesan
    Jiaming He
    Eric Fagerberg
    Jennifer L. Loza
    Darwin Kwok
    Aya Tal
    Jessica Buck
    Can Cui
    Jaiveer Singh
    William E. Damsky
    Jonathan S. Leventhal
    Smita Krishnaswamy
    Nikhil S. Joshi
    Nature, 2023, 619 : 151 - 159
12345